Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q1 2025 Earnings Conference Call May 19, 2025 8:30 AM ET
Company Participants
Joyce Lonergan – Investor Relations, LifeSci Advisors
Chaim Lebovits – President & Chief Executive Officer
Haro Hartounian – Executive Vice President & Chief Operating Officer
Bob Dagher – Executive Vice President & Chief Medical Officer
Netta Blondheim-Shraga – Senior Vice President, Research & Development
Conference Call Participants
Jason McCarthy – Maxim Group
David Bautz – Zacks Small-Cap
Operator
Greetings, and welcome to the Brainstorm Cell Therapeutics First Quarter 2025 Conference Call. At this time, all participants are in a listen-only mode. As a reminder, this call is being recorded.
I would now like to introduce your host for today’s call, Joyce Lonergan of LifeSci Advisors. Joyce, you may begin.
Joyce Lonergan
Thank you, Holly. Good morning, and thank you for joining us today.
Before passing the call to company management for prepared remarks, I would like to remind listeners that this conference call will contain numerous statements, descriptions, forecasts and projections regarding Brainstorm Cell Therapeutics and its potential future business operations and performance, statements regarding the market potential for the treatment of neurodegenerative disorders such as ALS, the sufficiency of the company’s existing capital resources for continuing operations in 2025 and beyond, the safety and clinical effectiveness of the NurOwn technology platform, clinical trials of NurOwn and related clinical development programs, and the company’s ability to develop strategic collaborations and partnerships to support their business planning efforts.
Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond Brainstorm’s control, including the risks and uncertainties described from time to time in its SEC filings. The company’s results may differ materially from those projected on today’s call. The company undertakes no obligation to publicly update any forward-looking statements.
Joining us
#Brainstorm #Cell #Therapeutics #BCLI #Earnings #Call #Transcript